IL6 and COVID-19: Conversely, some scholars, such as Yağmur et al. have demonstrated that IL-6 expression is lower in COVID-19 patients with OD than in those without, which is consistent with the findings of Dets et al. [54, 55], this phenomenon may be closely associated with the number of participants included, disease severity, or the sampling method and quality.